RV3 Rotavirus Vaccine: A human neonatal rotavirus vaccine for the Asia-Pacific region

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1012425

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Rotavirus infection is the leading cause of severe dehydrating gastroenteritis responsible for ~600,000 deaths per year in children <5 years of age worldwide. In this proposal we outline plans for the development of a human neonatal rotavirus vaccine in Indonesia. The goal is a safe and effective rotavirus vaccine affordable for children within the Asia-Pacific region and worldwide.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $2,264,330.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

child health | gastroenteritis | infectious diseases | prevention | rotavirus | rotavirus infection | vaccine efficacy | vaccine technology | vaccine-preventable diseases

Related Links